St. Louis, MO, United States of America

Katherine Cynthia Fuh

This inventor holds 6 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Leland Stanford Junior University, Aravive Biologics, Inc.. Active years: 2013-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katherine Cynthia Fuh. Retrieved from https://idiyas.com/inventor/katherine-cynthia-fuh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 66.7

 

 

Average Co-Inventor Count = 7.6

ph-index = 3

Forward Citations = 36(Granted Patents)


Location History:

  • Palo Alto, CA (US) (2013 - 2018)
  • St. Louis, MO (US) (2017 - 2021)

Company Filing History:


Years Active: 2013-2021

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Katherine Cynthia Fuh: A Pioneering Inventor in Cancer Therapy

Introduction

Katherine Cynthia Fuh, based in St. Louis, Missouri, is a remarkable inventor with a wealth of knowledge in the field of cancer therapy. With a total of six patents to her name, she is a leader in developing innovative solutions for complex medical challenges.

Latest Patents

Her latest contributions include groundbreaking patents focused on modified AXL peptides and their application in anti-metastatic therapy. These inventions provide compositions and methods for alleviating cancer in mammals by administering therapeutic doses that inhibit the activity of AXL, MER, or Tyro3 protein activity. Notably, her work highlights the competitive and non-competitive inhibition of the binding interaction between these proteins and their ligand, GAS6. Additionally, she has developed compositions and methods that alleviate liver fibrosis, endometriosis, kidney disease, inflammatory diseases, and transplant rejection, further showcasing her extensive expertise in this area.

Career Highlights

Katherine has been associated with prestigious institutions, such as Leland Stanford Junior University, where she honed her skills in research and innovation. Her work has significantly contributed to advancing cancer therapies through the development of her patent portfolio.

Collaborations

Throughout her career, Katherine has collaborated with esteemed colleagues, including Amato J. Giaccia and Erinn Bruno Rankin. These partnerships have facilitated the sharing of knowledge and expertise, fostering an environment of innovation and progress in their field.

Conclusion

Katherine Cynthia Fuh stands out as a prominent figure in the realm of medical innovation. Her dedication to research and her impressive patent portfolio reflect her commitment to improving treatment options for serious health conditions. Through her work, Katherine continues to inspire future generations of inventors and researchers in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…